Inhibition of matrix metalloproteinase-2 activity by siderophores of Pseudomonas species

Applied Microbiology and Biotechnology

Volumn 64, Issue 6, 2004, Pages 840-847

  Shinozaki, Y ^a   Akutsu Shigeno, Y ^a   Nakajima Kambe, T ^a   Inomata, S ^b   Nomura, N ^a   Nakahara, T ^a   Uchiyama, H ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b SHISEIDO RESEARCH CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; CHROMIUM; GELATIN; GELATINASE A; PYOVERDINE; SIDEROPHORE; ZINC ION;

BACTERIUM; BIOASSAY; ENZYME; ENZYME ACTIVITY; INHIBITION;

ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHELATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; FLUORESCENCE; NONHUMAN; PSEUDOMONAS; PURIFICATION; SOIL; SPECIES; ZYMOGRAPHY;

BINDING SITES; CHROMATOGRAPHY, LIQUID; HYDROXYBENZOIC ACIDS; MATRIX METALLOPROTEINASE 2; OLIGOPEPTIDES; PSEUDOMONAS; SIDEROPHORES; SOIL MICROBIOLOGY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; ZINC;

PSEUDOMONAS;

EID: 2342603044     PISSN: 01757598     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00253-003-1521-2     Document Type: Article

References (27)

1. Beckett RP, Davidson AH, Drummond AH, Huxley P, Whittaker M (1996) Recent advances in matrix metalloproteinase inhibitor research. Drug Discovery Today 1:16-26
2. Bochner BR (1989) 'Breathprints' at the microbial level. ASM News 55:536-539
3. Braun V, Braun M (2002) Iron transport and signaling in Escherichia coli. FEBS Lett 529:78-85
4. Braun V, Killmann H (1999) Bacterial solutions to the iron-supply problem. Trends Biochem Sci 24:104-109
5. Cornelis P, Matthijs S (2002) Diversity of siderophore-mediated iron uptake systems in fluorescent pseudomonads: not only pyoverdines. Environ Microbiol 4:787-798
6. Davies B, Brown PD, East N, Crimmin MJ, Balkwill FR (1993) A synthetic matrix metalloproteinase inhibitor decreases tumor burden and prolongs survival of mice bearing human ovarian carcinoma xenografts. Cancer Res 53:2087-2091
7. Deryugina EI, Ratnikov BI, Strongin AY (2003) Prinomastat, a hydroxamate inhibitor of matrix metalloproteinases, has a complex effect on migration of breast carcinoma cells. Int J Cancer 104:533-541
8. Donfrancesco A, Deb G, Dominici C, Pileggi D, Castello MA, Helson L (1990) Effects of a single course of deferoxamine in neuroblastoma patients. Cancer Res 50:4929-4930
9. Gendron R, Grenier D, Sorsa T, Uitto VJ, Mayrand D (1999) Effect of microbial siderophores on matrix metalloproteinase-2 activity. J Periodontal Res 34:50-53
10. Hohnadel D, Meyer JM (1988) Specificity of pyoverdine-mediated iron uptake among fluorescent Pseudomonas strains. J Bacteriol 170:4865-4873
11. Hrabec E, Strek M, Nowak D, Greger J, Suwalski M, Hrabec Z (2002) Activity of type IV collagenases (MMP-2 and MMP-9) in primary pulmonary carcinomas: a quantitative analysis. J Cancer Res Clin Oncol 128:197-204
12. Inomata S, Matsunaga Y, Amano S, Takada K, Kobayashi K, Tsunenaga M, Nishiyama T, Kohno Y, Fukuda M (2003) Possible involvement of gelatinases in basement membrane damage and wrinkle formation in chronically ultraviolet B-exposed hairless mouse. J Invest Dermatol 120:128-134
13. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58:1048-1051
14. Kicic A, Chua AC, Baker E (2002) Desferrithiocin is a more potent antineoplastic agent than desferrioxamine. Br J Pharmacol 135:1393-1402
15. Kilz S, Lenz C, Fuchs R, Budzikiewicz H (1999) A fast screening method for the identification of siderophores from fluorescent Pseudomonas spp. by liquid chromatography/electrospray mass spectrometry. J Mass Spectrom 34:281-290
16. Liotta LA (1986) Tumor invasion and metastases: role of the extracellular matrix: Rhoads memorial award lecture. Cancer Res 46:1-7
17. Liotta LA, Tryggvason K, Garbisa S, Hart I, Foltz CM, Shafie S (1980) Metastatic potential correlates with enzymatic degradation of basement membrane collagen. Nature 284:67-68
18. Maekawa R, Maki H, Yoshida H, Hojo K, Tanaka H, Wada T, Uchida N, Takeda Y, Kasai H, Okamoto H, Tsuzuki H, Kambayashi Y, Watanabe F, Kawada K, Toda K, Ohtani M, Sugita K, Yoshioka T (1999) Correlation of antiangiogenic and antitumor efficacy of N-biphenyl sulfonyl-phenylalanine hydroxiamic acid (BPHA), an orally-active, selective matrix metalloproteinase inhibitor. Cancer Res 59:1231-1235
19. McCall KA, Fierke CA (2000) Colorimetric and fluorimerric assays to quantitate micromolar concentrations of transition metals. Anal Biochem 284:307-315
20. Meyer JM (2000) Pyoverdines: pigments, siderophores and potential taxonomic markers of fluorescent Pseudomonas species. Arch Microbiol 174:135-142
21. Meyer JM, Stintzi A, Poole K (1999) The ferripyoverdine receptor FpvA of Pseudomonas aeruginosa PAO1 recognizes the ferripyoverdines of P. aeruginosa PAO1 and P. fluorescens ATCC 13525. FEMS Microbiol Lett 170:145-150
22. Neilands JB (1995) Siderophores: structure and function of microbial iron transport compounds. J Biol Chem 270:26723-26726
23. O-Charoenrat P, Rhys-Evans P, Eccles S (2002) A synthetic matrix metalloproteinase inhibitor prevents squamous carcinoma cell proliferation by interfering with epidermal growth factor receptor autocrine loops. Int J Cancer 100:527-533
24. Payne SM (1994) Detection, isolation, and characterization of siderophores. Methods Enzymol 235:329-344
25. Schwyn B, Neilands JB (1987) Universal chemical assay for the detection and determination of siderophores. Anal Biochem 160:47-56
26. Whittaker M, Floyd CD, Brown P, Gearing AJ (1999) Design and therapeutic application of matrix metalloproteinase inhibitors. Chem Rev 99:2735-2776
27. Xiao R, Kisaalita WS (1995) Purification of pyoverdines of Pseudomonas fluorescens 2-79 by copper-chelate chromatography. Appl Environ Microbiol 61:3769-3774